Presentation
|
7
|
Resverlogix Corp.
|
Oct 04, 2021 05:03PM
|
Progress
|
5
|
Resverlogix Corp.
|
Dec 08, 2021 11:42AM
|
Prostate Cancer News Today Article
|
4
|
Zenith Epigenetics
|
Jul 03, 2019 01:07PM
|
Qatar Research overview of apabetalone
|
4
|
Resverlogix Corp.
|
Apr 23, 2024 08:38PM
|
Qatar Research overview of apabetalone
|
1
|
Resverlogix Corp.
|
Apr 23, 2024 08:41PM
|
Qatar Research overview of apabetalone
|
3
|
Resverlogix Corp.
|
Apr 23, 2024 08:41PM
|
Question
|
4
|
Resverlogix Corp.
|
Feb 23, 2021 01:37PM
|
Question for posters
|
13
|
Resverlogix Corp.
|
Dec 09, 2021 12:13PM
|
Question for the experts
|
1
|
Zenith Epigenetics
|
Oct 08, 2024 12:32PM
|
Question re BOD votes
|
3
|
Resverlogix Corp.
|
Jun 25, 2022 11:39AM
|
Question re Hepa
|
6
|
Resverlogix Corp.
|
Oct 18, 2017 11:14AM
|
Rambling thoughts re 2017 and the future
|
2
|
Resverlogix Corp.
|
Jan 04, 2018 04:05PM
|
Random thoughts in the vacuum of information
|
7
|
Resverlogix Corp.
|
Jun 27, 2024 12:37PM
|
Re: "Later this quarter we'll announce some orphan indications that we'll be going..
|
3
|
Resverlogix Corp.
|
Jul 15, 2015 12:37PM
|
Re: "reversing tactics to decelerate momentum"
|
5
|
Resverlogix Corp.
|
Oct 29, 2015 05:00PM
|
Re: #ESCCongress 2019 round-up
|
2
|
Resverlogix Corp.
|
Sep 09, 2019 04:09PM
|
Re: $100 million dollar question
|
4
|
Resverlogix Corp.
|
Jun 13, 2017 04:43PM
|
Re: $60m PP Question
|
4
|
Zenith Epigenetics
|
Jan 04, 2018 04:44PM
|
Re: (one) case study
|
5
|
Zenith Epigenetics
|
Oct 03, 2018 06:39PM
|
Re: ... keeping it simple...
|
5
|
Resverlogix Corp.
|
Nov 06, 2017 11:46AM
|